Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06529094 · ClinicalTrials.gov registry record · NA
Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic
A NA study of Spinal Cord Injury and Pressure Injury, sponsored by VA Office of Research and Development.
- Recruiting
- Registry status
- NA
- Development phase
- 808
- Enrollment target
- 7
- Study locations
NCT06529094: Recruiting NA study of Spinal Cord Injury and Pressure Injury, sponsored by VA Office of Research and Development.
NCT06529094 is a NA study of Spinal Cord Injury and Pressure Injury that is actively recruiting participants, run by VA Office of Research and Development. The registered enrollment target is 808 participants, above the 78-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (936% higher). The trial reports 7 study locations across 6 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06529094, a NA study of Spinal Cord Injury and Pressure Injury, is actively recruiting participants, sponsored by VA Office of Research and Development.
- RECRUITING
- Registry status
- NA
- Development phase
- 808 participants
- Enrollment target
- 7
- Study locations
Study Summary
Spinal cord injury (SCI) is a permanent condition affecting every aspect of life including health, daily activities, and participation and quality of life. Persons with SCI are at high risk of pressure injury (PrI) throughout their lives due to loss of sensation, nerve damage and immobility. PrIs are local areas of damage to the skin and underlying soft tissue caused by pressure and shear commonly located over bony prominences. While most PrIs are hospital- or nursing home-acquired, in people with SCI, PrIs typically develop in the community. Community-acquired pressure injuries (CAPrIs) are common, devastating, and costly. This grant proposal will assess how well a decision support tool, called the Community Acquired Pressure Injury Prevention Field Implementation Tool (CAPP-FIT), is used in the clinic and how well it prevents CAPrIs. The CAPP-FIT will be implemented at seven sites across the country in a staggered fashion. The CAPP-FIT includes: 1) an automated Veteran survey to identify risks, actions, and resources needed to prevent CAPrIs and 2) a companion Provider Report immediately available in the electronic health record listing Veteran responses to survey items with recommended evidence-based provider actions. The Veteran survey can be completed via a secured email on the computer or phone. There are three aims in the proposal: Aim 1 is implementing the CAPP-FIT at the seven geographically diverse VA SCI clinics. After CAPP-FIT implementation, each site will determine how the CAPP-FIT will be maintained in clinical practice to support sustainability. Aim 2 assesses how well the CAPP-FIT prevents CAPrIs and CAPrI-associated hospitalizations and assesses provider and Veteran satisfaction. Aim 3 assesses how well the CAPP-FIT is implemented in the SCI clinic.
Primary Outcome
New CAPrI incidence within 6 months of first CAPP-FIT survey measured for each unique patient
Conditions Studied
Interventions
- BEHAVIORAL Provider training
- BEHAVIORAL CAPP-FIT intervention with RA facilitation
- BEHAVIORAL CAPP-FIT implementation during maintenance phase
Study Locations (7)
California
- VA Long Beach Healthcare System, Long Beach, CA - Long Beach
- VA Palo Alto Health Care System, Palo Alto, CA - Palo Alto
Florida
- James A. Haley Veterans' Hospital, Tampa, FL - Tampa
Illinois
- Edward Hines Jr. VA Hospital, Hines, IL - Hines
Missouri
- St. Louis VA Medical Center John Cochran Division, St. Louis, MO - St Louis
Ohio
- Louis Stokes VA Medical Center, Cleveland, OH - Cleveland
Texas
- Michael E. DeBakey VA Medical Center, Houston, TX - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 808 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2028-07-31 |
| Phase | NA |
What NCT06529094 shows while recruiting
NCT06529094 is an interventional study that assigns participants to a tested intervention. The registered 808 participants enrollment target is mid-sized for trials with a published cap, above the 78-participant average among 99 other Spinal Cord Injury trials with a reported enrollment target (936% higher).
The record links to 2 conditions, with Spinal Cord Injury appearing as the primary indexed condition, and to 3 interventions - of which Provider training is the first listed.
NCT06529094 lists 7 locations in 6 states (California, Florida, Illinois).
Frequently Asked Questions
What is clinical trial NCT06529094 about?
NCT06529094 is a clinical study titled "Implementing a Decision Support Tool to Prevent Community-Acquired Pressure Injury in Spinal Cord Injury (SCI) in the Spinal Cord Injury Clinic". Spinal cord injury (SCI) is a permanent condition affecting every aspect of life including health, daily activities, and participation and quality of life. Persons with SCI are at high risk of pressure injury (PrI) throughout their lives due to loss of sensation, nerve damage and immobility. PrIs ar...
What is the current status of trial NCT06529094?
This trial is currently recruiting. It is a NA study. The enrollment target is 808 participants. The study started on 2024-11-01. Estimated completion is 2028-07-31.
What conditions does trial NCT06529094 study?
This clinical trial studies the following conditions: Spinal Cord Injury, Pressure Injury.
What interventions are being tested in trial NCT06529094?
The interventions under investigation include: Provider training (BEHAVIORAL), CAPP-FIT intervention with RA facilitation (BEHAVIORAL), CAPP-FIT implementation during maintenance phase (BEHAVIORAL).
Who is sponsoring clinical trial NCT06529094?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06529094 being conducted?
This trial has 7 study locations across California, Florida, Illinois, Missouri, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Spinal Cord Injury
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06529094's enrollment target sits among peer trials
808 3rd of 99 higher than 97 of 99 other Spinal Cord Injury trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Spinal Cord Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cortical Recording and Stimulating Array Brain-Machine Interface
RECRUITING · NA
-
Clinical Outcome Assessment for AT & BCI
RECRUITING · NA
-
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
RECRUITING · NA
-
SCI&U Peer Health Coaching Program for Individuals Newly Discharged From Inpatient Rehabilitation
RECRUITING · NA
-
At-Home Genital Nerve Stimulation for SCI Bowel
RECRUITING · NA
-
Exoskeleton and Spinal Cord Stimulation for SCI
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05519085 · 810 participants · Phase 3
A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)
- NCT04613596 · 806 participants · Phase 2
Phase 2 Trial of Adagrasib Monotherapy and in Combination With Pembrolizumab and a Phase 3 Trial of Adagrasib in Combination in Patients With a KRAS G12C Mutation KRYSTAL-7
- NCT06065098 · 806 participants · NA
Church-based Health Intervention to Eliminate Racial Inequalities in Cardiovascular Health
- NCT04423211 · 804 participants · Phase 3
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI